[A novel molecular target therapeutics for refractory prostate cancer]

Nihon Rinsho. 2002 Dec:60 Suppl 11:272-7.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Alitretinoin
  • Androgens*
  • Angiotensin Receptor Antagonists
  • Animals
  • Benzimidazoles / therapeutic use
  • Biphenyl Compounds
  • Cholecalciferol / therapeutic use
  • DNA-Binding Proteins
  • Drug Design
  • Genistein / therapeutic use
  • Humans
  • Male
  • Neoplasms, Hormone-Dependent / drug therapy*
  • Neoplasms, Hormone-Dependent / etiology
  • Prostatic Neoplasms / drug therapy*
  • Prostatic Neoplasms / etiology
  • Receptor, Angiotensin, Type 1
  • Receptors, Angiotensin / physiology
  • Telomerase / antagonists & inhibitors
  • Tetrazoles / therapeutic use
  • Tretinoin / therapeutic use

Substances

  • Androgens
  • Angiotensin Receptor Antagonists
  • Benzimidazoles
  • Biphenyl Compounds
  • DNA-Binding Proteins
  • Receptor, Angiotensin, Type 1
  • Receptors, Angiotensin
  • Tetrazoles
  • Cholecalciferol
  • Alitretinoin
  • Tretinoin
  • Genistein
  • Telomerase
  • candesartan